J9305
J9305 – Injection, pemetrexed, not otherwise specified, 10 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 50 NDCs crosswalked per 10 MG $6.952/unit ASP+6%
📋 J9305 summary
J9305 is a HCPCS Level II J-code used to bill pemetrexed, not otherwise specified, 10 mg, billed per 10 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J9305: Alimta*, Alimta, Pemetrexed
Code J9305
Billing unit 10 MG Payment limit $6.952/unit NDC-Crosswalk 50
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ9305
DescriptorInjection, pemetrexed, not otherwise specified, 10 mg
Billing unit10 MG
Payment limit / unit$6.952
Est. ASP / unit$6.558 est.
Mapped NDCs50
Data periodQ3 2026
Last updated2026-08-20
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$6.952
Est. ASP / unit
$6.558 est.
Est. after 2% sequester
$6.813
HCPCS dosage
10 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, pemetrexed, not otherwise specified, 10 mg
CoverageC — Carrier/MAC judgment
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment groupYY
Action codeN — No maintenance this year
Effective date2020-10-01
Date added2005-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J9305 = 10 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J9305 WITH EST. MEDICARE PAY
50 NDCs map to J9305. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($6.952/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00002-7623-01 | Alimta Pemetrexed disodium 500 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Eli | 1 VIAL in 1 CARTON (0002-7623-01) / 20 mL... | 500 mg/20mL | 50 | $347.60 | — | ● Active | CMS + PDAC |
| 00002-7640-01 | Alimta Pemetrexed disodium 100 mg/4mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Eli | 1 VIAL in 1 CARTON (0002-7640-01) / 4 mL... | 100 mg/4mL | 10 | $69.52 | — | ● Active | CMS + PDAC |
| 25021-0260-10 | Pemetrexed 100 mg/4.2mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Sagent | 1 VIAL in 1 CARTON (25021-260-10) / 4.2 m... | 100 mg/4.2mL | 10 | $69.52 | — | ● Active | CMS + PDAC |
| 25021-0261-50 | Pemetrexed 500 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Sagent | 1 VIAL in 1 CARTON (25021-261-50) / 20 mL... | 500 mg/20mL | 50 | $347.60 | — | ● Active | CMS + PDAC |
| 43598-0370-74 | Pemetrexed disodium 1 g/40mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Dr. | 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-370... | 1 g/40mL | 100 | $695.20 | — | ● Active | CMS ASP |
| 43598-0386-62 | Pemetrexed disodium 100 mg/4mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Dr. | 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-386... | 100 mg/4mL | 10 | $69.52 | — | ● Active | CMS + PDAC |
| 43598-0387-11 | Pemetrexed disodium 500 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Dr. | 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-387... | 500 mg/20mL | 50 | $347.60 | — | ● Active | CMS + PDAC |
| 50742-0341-01 | Pemetrexed | Ingenus | — | — | 50 | $347.60 | — | — | CMS + PDAC |
| 55150-0381-01 | Pemetrexed 100 mg/4mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Eugia | 1 VIAL in 1 CARTON (55150-381-01) / 4 mL... | 100 mg/4mL | 10 | $69.52 | — | ● Active | CMS + PDAC |
| 55150-0382-01 | Pemetrexed 500 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Eugia | 1 VIAL in 1 CARTON (55150-382-01) / 20 mL... | 500 mg/20mL | 50 | $347.60 | — | ● Active | CMS + PDAC |
| 55150-0383-01 | Pemetrexed 1000 mg/40mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Eugia | 1 VIAL in 1 CARTON (55150-383-01) / 40 mL... | 1000 mg/40mL | 100 | $695.20 | — | ● Active | CMS ASP |
| 60505-6065-00 | Pemetrexed | Apotex | — | — | 10 | $69.52 | — | — | CMS + PDAC |
| 60505-6066-00 | Pemetrexed | Apotex | — | — | 50 | $347.60 | — | — | CMS + PDAC |
| 60505-6067-00 | Pemetrexed | Apotex | — | — | 100 | $695.20 | — | — | CMS ASP |
| 60505-6068-00 | Pemetrexed 750 mg/30mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Apotex | 1 VIAL in 1 CARTON (60505-6068-0) / 30 mL... | 750 mg/30mL | 75 | $521.40 | — | Obsolete | CMS ASP |
| 63323-0134-10 | Pemetrexed 100 mg/4mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Fresenius | 1 VIAL, SINGLE-USE in 1 CARTON (63323-134-... | 100 mg/4mL | 10 | $69.52 | — | ● Active | CMS + PDAC |
| 63323-0450-50 | Pemetrexed 500 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Fresenius | 1 VIAL, SINGLE-USE in 1 CARTON (63323-450-... | 500 mg/20mL | 50 | $347.60 | — | ● Active | CMS + PDAC |
| 68001-0535-41 | Pemetrexed 100 mg/4mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BluePoint | 1 VIAL in 1 CARTON (68001-535-41) / 4 mL... | 100 mg/4mL | 10 | $69.52 | — | ● Active | CMS + PDAC |
| 68001-0536-41 | Pemetrexed 500 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BluePoint | 1 VIAL in 1 CARTON (68001-536-41) / 20 mL... | 500 mg/20mL | 50 | $347.60 | — | ● Active | CMS + PDAC |
| 68001-0538-41 | Pemetrexed 100 mg/4mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BluePoint | 1 VIAL in 1 CARTON (68001-538-41) / 4 mL... | 100 mg/4mL | 10 | $69.52 | — | ● Active | CMS + PDAC |
| 68001-0539-41 | Pemetrexed 500 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BluePoint | 1 VIAL in 1 CARTON (68001-539-41) / 20 mL... | 500 mg/20mL | 50 | $347.60 | — | ● Active | CMS + PDAC |
| 68001-0543-41 | Pemetrexed 100 mg/4mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BluePoint | 1 VIAL in 1 CARTON (68001-543-41) / 4 mL... | 100 mg/4mL | 10 | $69.52 | — | ● Active | CMS + PDAC |
| 68001-0544-41 | Pemetrexed 500 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BluePoint | 1 VIAL in 1 CARTON (68001-544-41) / 20 mL... | 500 mg/20mL | 50 | $347.60 | — | ● Active | CMS + PDAC |
| 68001-0545-41 | Pemetrexed 750 mg/30mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BluePoint | 1 VIAL in 1 CARTON (68001-545-41) / 30 mL... | 750 mg/30mL | 75 | $521.40 | — | ● Active | CMS ASP |
| 68001-0546-41 | Pemetrexed 1000 mg/40mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BluePoint | 1 VIAL in 1 CARTON (68001-546-41) / 40 mL... | 1000 mg/40mL | 100 | $695.20 | — | ● Active | CMS ASP |
| 70069-0834-01 | Pemetrexed 100 mg/4mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Somerset | 1 VIAL in 1 CARTON (70069-834-01) / 4 mL... | 100 mg/4mL | 10 | $69.52 | — | ● Active | CMS + PDAC |
| 70069-0835-01 | Pemetrexed 500 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Somerset | 1 VIAL in 1 CARTON (70069-835-01) / 20 mL... | 500 mg/20mL | 50 | $347.60 | — | ● Active | CMS + PDAC |
| 70710-1654-01 | pemetrexed 100 mg/4mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Zydus | 1 VIAL in 1 CARTON (70710-1654-1) / 4 mL... | 100 mg/4mL | 10 | $69.52 | — | ● Active | CMS + PDAC |
| 70710-1655-01 | pemetrexed 500 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Zydus | 1 VIAL in 1 CARTON (70710-1655-1) / 20 mL... | 500 mg/20mL | 50 | $347.60 | — | ● Active | CMS + PDAC |
| 70710-1674-01 | pemetrexed 1000 mg/40mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Zydus | 1 VIAL in 1 CARTON (70710-1674-1) / 40 mL... | 1000 mg/40mL | 100 | $695.20 | — | ● Active | CMS ASP |
| 70860-0202-10 | Pemetrexed | Athenex | — | — | 10 | $69.52 | — | — | CMS ASP |
| 70860-0203-50 | Pemetrexed | Athenex | — | — | 50 | $347.60 | — | — | CMS ASP |
| 71288-0147-50 | Pemetrexed 750 mg/30mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Meitheal | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-147... | 750 mg/30mL | 75 | $521.40 | — | ● Active | CMS ASP |
| 71288-0148-51 | Pemetrexed 1 g/40mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Meitheal | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-148... | 1 g/40mL | 100 | $695.20 | — | ● Active | CMS ASP |
| 71288-0166-10 | Pemetrexed 100 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Meitheal | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-166... | 100 mg/10mL | 10 | $69.52 | — | Obsolete | CMS + PDAC |
| 71288-0166-91 | Pemetrexed 100 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Meitheal | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-166... | 100 mg/10mL | 10 | $69.52 | — | Obsolete | CMS + PDAC |
| 71288-0166-92 | Pemetrexed 100 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Meitheal | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-166... | 100 mg/10mL | 10 | $69.52 | — | Obsolete | CMS + PDAC |
| 71288-0167-50 | Pemetrexed 500 mg/50mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Meitheal | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-167... | 500 mg/50mL | 50 | $347.60 | — | Obsolete | CMS + PDAC |
| 71288-0167-95 | Pemetrexed 500 mg/50mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Meitheal | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-167... | 500 mg/50mL | 50 | $347.60 | — | Obsolete | CMS + PDAC |
| 71288-0167-96 | Pemetrexed 500 mg/50mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Meitheal | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-167... | 500 mg/50mL | 50 | $347.60 | — | Obsolete | CMS + PDAC |
| 72603-0325-01 | Pemetrexed 100 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NorthStar | 1 VIAL, SINGLE-DOSE in 1 CARTON (72603-325... | 100 mg/10mL | 10 | $69.52 | — | ● Active | CMS + PDAC |
| 72603-0425-01 | Pemetrexed 500 mg/50mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NorthStar | 1 VIAL, SINGLE-DOSE in 1 CARTON (72603-425... | 500 mg/50mL | 50 | $347.60 | — | ● Active | CMS + PDAC |
| 43547-0632-01 | Pemetrexed 100 mg/1 INJECTION, POWDER, FOR SOLUTION | Solco | 100 INJECTION, POWDER, FOR SOLUTION in 1 V... | 100 mg/1 | 10 | $69.52 | — | ● Active | PDAC |
| 16729-0229-03 | PEMETREXED 100 mg/4mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Accord | 1 VIAL in 1 CARTON (16729-229-03) / 4 mL... | 100 mg/4mL | 10 | $69.52 | — | ● Active | PDAC |
| 50742-0340-01 | PEMETREXED (SDV,LYOPHILIZED) 100 MG | Unknown | — | — | 10 | $69.52 | — | — | PDAC |
| 16729-0230-11 | PEMETREXED 500 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Accord | 1 VIAL in 1 CARTON (16729-230-11) / 20 mL... | 500 mg/20mL | 50 | $347.60 | — | ● Active | PDAC |
| 00338-0722-01 | PEMETREXED (SDV,LYOPHILIZED) 500 MG | Unknown | — | — | 50 | $347.60 | — | — | PDAC |
| 00338-0720-01 | PEMETREXED (SDV,LYOPHILIZED) 100 MG | Unknown | — | — | 10 | $69.52 | — | — | PDAC |
| 00409-1061-01 | PEMETREXED (SDV,PF,LATEX-FREE) 500 MG | Unknown | — | — | 50 | $347.60 | — | — | PDAC |
| 00409-1060-01 | PEMETREXED (SDV,PF,LATEX-FREE) 100 MG | Unknown | — | — | 10 | $69.52 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$4.17M
Claims
13,253
Beneficiaries
5,711
Spend / beneficiary
$730.65
Spend / claim
$314.85
Trend by period
Where J9305 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #255 of 824
#250
TOFIDENCE Q5133
$4.45M
#251
HERZUMA Q5113
$4.43M
#252
GENVISC 850 J7320
$4.4M
#253
LANREOTIDE ACETATE(J... J1932
$4.36M
#254
PURAPLY AM 1 SQ CM** Q4196
$4.19M
#255
ALIMTA* J9305
$4.17M
#256
DYSPORT J0586
$4.16M
#257
APLIGRAF Q4101
$4.15M
#258
INFED J1750
$4.11M
#259
ONPATTRO J0222
$4.09M
#260
ILUVIEN J7313
$4.02M
Total claims — #143 of 824
#138
MVASI Q5107
13,685
#139
ACTIVASE* J2997
13,490
#140
LUCENTIS J2778
13,447
#141
INFED J1750
13,385
#142
GENTAMICIN SULFATE I... J1580
13,327
#143
ALIMTA* J9305
13,253
#144
TECENTRIQ J9022
13,217
#145
HIZENTRA J1559
13,119
#146
IPRATROPIUM BROMIDE J7644
12,953
#147
ERTAPENEM J1335
12,875
#148
ENGERIX-B ADULT(9074... 90746
12,582
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $4.17M | 5,711 | 13,253 | $730.65 | $314.85 |
| 2025 (Q1-Q4) | $21.79M | 13,159 | 58,354 | $1,655.69 | $373.36 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$5.29M
Medicare paid
$4.07M
Submitted services
1,313,114
Denial rate
5.1%
Allowed / service
$4.25
Submitted charges
$165.45M
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J9305 is utilized CMS · BY PROVIDER · 2024
Medicare Part B services for this code by the rendering provider's state — 88,565 services across 13 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.
Hover or tap a state to see its numbers + top ZIP codes.
Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.
📊 What bills under J9305
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
50 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J9305 billing FAQ
What is HCPCS code J9305?
J9305 is a HCPCS Level II J-code used to bill Injection, pemetrexed, not otherwise specified, 10 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J9305?
One unit of J9305 represents 10 MG. Report the number of units equal to the dose administered divided by 10 MG.
How many units of J9305 should I bill?
Divide the dose administered by the code's unit size (10 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J9305?
The Medicare Part B payment limit is $6.952 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $6.813 per unit. Payment limits are revised quarterly.
Which NDCs bill under J9305?
50 NDCs currently map to J9305 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J9305 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.